Robyn Carlisle, MSN, CNM, WHNP, works as a full-scope midwife at University Doctors and Kennedy University Hospital in Sewell, N.J. A graduate of University of Miami and University of Pennsylvania, her areas of interest include adolescent medicine, women's health and natural childbirth. Robyn is married with two sons and enjoys running and travel in what little spare time she can find.
May 20, 2013
Testing for the breast-cancer susceptibility genes BRCA1 and BRCA2 is costly and not a standard screening tool for the general patient population.
The Komen Foundation's decisions to withdraw and then reinstate Planned Parenthood breast-screening funding highlight disturbing trends in health care.
Many expecting mothers' birth plans border on accusatory and convey a general sense of mistrust of the medical community.
Women are increasingly asking health care providers for help with their sex life.
Is genetic screening evolving into a commodity to help couples conceive designer babies?
